CoChat

Mechanisms Linking Inflammation to Insulin Resistance

Open access
Chen, Li, Chen, Rui, Wang, Hua, Liang, Fengxia · 2015 · International Journal of Endocrinology

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Abstract

Obesity is now widespread around the world. Obesity-associated chronic low-grade inflammation is responsible for the decrease of insulin sensitivity, which makes obesity a major risk factor for insulin resistance and related diseases such as type 2 diabetes mellitus and metabolic syndromes. The state of low-grade inflammation is caused by overnutrition which leads to lipid accumulation in adipocytes. Obesity might increase the expression of some inflammatory cytokines and activate several signaling pathways, both of which are involved in the pathogenesis of insulin resistance by interfering with insulin signaling and action. It has been suggested that specific factors and signaling pathways are often correlated with each other; therefore, both of the fluctuation of cytokines and the status of relevant signaling pathways should be considered during studies analyzing inflammation-related insulin resistance. In this paper, we discuss how these factors and signaling pathways contribute to insulin resistance and the therapeutic promise targeting inflammation in insulin resistance based on the latest experimental studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2015/508409

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Influence of the inflammatory cytokines on the status of insulin resistance. TNF-α causes insulin resistance by enhancing adipocyte lipolysis stimulating JNK and IKKβ/NF-κB pathway which may increase serine/threonine phosphorylation of IRS1. IL-6 induces IR by reducing the expression of GLUT4 and IRS-1 by activating the JAK-STAT signaling pathway and increasing SOCS3 expression, and IL-6 can also lead to IR in skeletal muscle by inducing TLR-4 gene expression through activation of STAT3; besides, TLR4 is suggested to be major upstream molecules in the activation of NF-κB. Besides, IL-6 is also found to induce IR by impairing the synthesis of glycogen through downregulating the expression of miR-200s and upregulating that of FOG-2.
Figure 1 Influence of the inflammatory cytokines on the status of insulin resistance. TNF-α causes insulin resistance by enhancing adipocyte lipolysis stimulating JNK and IKKβ/NF-κB pathway which may increase serine/threonine phosphorylation of IRS1. IL-6 induces IR by reducing the expression of GLUT4 and IRS-1 by activating the JAK-STAT signaling pathway and increasing SOCS3 expression, and IL-6 can also lead to IR in skeletal muscle by inducing TLR-4 gene expression through activation of STAT3; besides, TLR4 is suggested to be major upstream molecules in the activation of NF-κB. Besides, IL-6 is also found to induce IR by impairing the synthesis of glycogen through downregulating the expression of miR-200s and upregulating that of FOG-2.CC BY · PubMed Central
Figure 2 Inflammatory pathways linking inflammation to insulin resistance. Activation of JNK and NF-κB pathways causes serine kinase phosphorylation of IRS-1 or IRS-2, which may block insulin signaling and finally lead to the occurrence of IR. In addition, JNK and NF-κB pathways are involved in the production of proinflammatory cytokines which may in turn become activation stimuli of the pathways.
Figure 2 Inflammatory pathways linking inflammation to insulin resistance. Activation of JNK and NF-κB pathways causes serine kinase phosphorylation of IRS-1 or IRS-2, which may block insulin signaling and finally lead to the occurrence of IR. In addition, JNK and NF-κB pathways are involved in the production of proinflammatory cytokines which may in turn become activation stimuli of the pathways.CC BY · PubMed Central
Figure 3 Inflammasome pathway and macrophages are involved in development of insulin resistance. The secretion of IL-β and IL-18 can be regulated by inflammasome pathway. Inflammasome consists of a large group of cytosolic protein complexes including NLRP3 and caspase-1. NLRP3 can be activated by mitochondrial dysfunction through causing ROS accumulation, and NLRP3 is also a novel molecular link between saturated FFA and chronic inflammation. Caspase-1 mediates macrophages that infiltrate into adipose tissues. Dietary saturated fatty acids lead to activation of TLR2 and TLR4 in ATMs, giving rise to the activation of IRF3, JNK, and NF-κB.
Figure 3 Inflammasome pathway and macrophages are involved in development of insulin resistance. The secretion of IL-β and IL-18 can be regulated by inflammasome pathway. Inflammasome consists of a large group of cytosolic protein complexes including NLRP3 and caspase-1. NLRP3 can be activated by mitochondrial dysfunction through causing ROS accumulation, and NLRP3 is also a novel molecular link between saturated FFA and chronic inflammation. Caspase-1 mediates macrophages that infiltrate into adipose tissues. Dietary saturated fatty acids lead to activation of TLR2 and TLR4 in ATMs, giving rise to the activation of IRF3, JNK, and NF-κB.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Research works printed but not linked: 4

  1. 2015, Journal of Sports Science and Medicine, 14, 103
  2. 10.4149/endo_2009_04_157 · doi:10.4149/endo_2009_04_157
  3. 2014, European Review for Medical and Pharmacological Sciences, 18, 575
  4. 2007, Kobe Journal of Medical Sciences, 53, 345

Cited by

Items 401–500 of 683

Metadata

Authors
Chen, L., Chen, R., Wang, H., & Liang, F.
Affiliations
  • Hubei University of Chinese Medicine (CN)
  • Wuhan Union Hospital (CN)
Corresponding author
Liang, Fengxia
Venue
International Journal of Endocrinology
Publisher
Wiley
Published
2015
Volume
2015
Pages
1-9
ISSN
  • 1687-8337 (ISSN-L)
  • 1687-8345
OpenAlex
W1531763753
Cited by
644
References
91
Citations by year
2026: 42 · 2025: 67 · 2024: 62 · 2023: 49 · 2022: 62 · 2021: 87 · 2020: 81 · 2019: 74 · 2018: 55 · 2017: 35 · 2016: 25 · 2015: 4
FWCI
5.16
Type
journal article
Language
en
Open access
Locations
  • International Journal of Endocrinology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81001557, 81473787)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
insulin resistance, low-grade inflammation, obesity, type 2 diabetes, metabolic syndrome, inflammatory cytokines, adipocytes, lipid accumulation, insulin signaling, signaling pathways, anti-inflammatory therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.